Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-26

FDA Approved: ONDANSETRON HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma's ondansetron hydrochloride as a generic product (ANDA) for the prevention of nausea and vomiting, adding another generic antiemetic option.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

ORIG AP for ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)